A Study of Various Treatments in Serous or p53 Abnormal Endometrial Cancer
Clinical trial NCT04159155 · TERMINATED
Trial details
- NCT number
- NCT04159155
- Sponsor
- University Health Network, Toronto
- Status
- TERMINATED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2020-11-17
- Primary completion
- 2025-05-26
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.